Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 475 of 3284 entries
View as:

Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01530334 Org: User:
Start: 07/31/12 End: 07/31/14 Due: 07/31/15

Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly

Phase: N/A Priority: Normal
NCT ID: NCT00585143 Org: User:
Start: 01/31/08 End: 10/31/08 Due: 10/31/09

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8233 in Healthy Male Subjects With Increased Elevated LDL-C Levels.

Phase: N/A Priority: Normal
NCT ID: NCT03593785 Org: User:
Start: 08/03/18 End: 12/19/20 Due: 12/19/21

Asthma in Children

Phase: N/A Priority: Normal
NCT ID: NCT01286532 Org: User:
Start: 04/30/11 End: 10/31/12 Due: 10/31/13

A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience

Phase: N/A Priority: Normal
NCT ID: NCT01043185 Org: User:
Start: 12/31/09 End: 05/31/10 Due: 05/31/11

Rosuvastatin Adherence App Study in China

Phase: N/A Priority: Normal
NCT ID: NCT02433288 Org: User:
Start: 07/20/15 End: 10/28/16 Due: 10/28/17

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00326105 Org: User:
Start: 04/30/06 End: 07/31/07 Due: 07/31/08

A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Phase: N/A Priority: Normal
NCT ID: NCT00374907 Org: User:
Start: 09/30/06 End: 12/31/09 Due: 12/31/10

Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00228488 Org: User:
Start: 06/30/04 End: 12/31/05 Due: 12/31/06

Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877

Phase: N/A Priority: Normal
NCT ID: NCT00471367 Org: User:
Start: 04/30/07 End: 12/31/08 Due: 12/31/09

Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]Adavosertib

Phase: N/A Priority: Normal
NCT ID: NCT05008913 Org: User:
Start: 10/01/21 End: 11/16/21 Due: 11/16/22

Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00322595 Org: User:
Start: 05/31/06 End: 05/31/07 Due: 05/31/08

A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients

Phase: N/A Priority: Normal
NCT ID: NCT01396226 Org: User:
Start: 09/30/11 End: 01/31/12 Due: 01/31/13

Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)

Phase: N/A Priority: Normal
NCT ID: NCT05516498 Org: User:
Start: 10/31/22 End: 08/15/25 Due: 08/15/26

G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)

Phase: N/A Priority: Normal
NCT ID: NCT00255645 Org: User:
Start: 09/30/05 End: 12/31/06 Due: 12/31/07

Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial

Phase: N/A Priority: Normal
NCT ID: NCT00540059 Org: User:
Start: 06/30/05 End: - Due: -

Assess the Absorption, Distribution, Metabolism and Excretion of AZD7325 After Intravenous and Oral Administration

Phase: N/A Priority: Normal
NCT ID: NCT00940641 Org: User:
Start: 08/31/09 End: 10/31/09 Due: 10/31/10

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06879041 Org: User:
Start: 03/10/25 End: 04/16/29 Due: 04/16/30

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

Phase: N/A Priority: Normal
NCT ID: NCT06932263 Org: User:
Start: 03/26/25 End: 03/16/28 Due: 03/16/29

Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)

Phase: N/A Priority: Normal
NCT ID: NCT04157335 Org: User:
Start: 11/25/19 End: 04/07/25 Due: 04/07/26

Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.

Phase: N/A Priority: Normal
NCT ID: NCT06376097 Org: User:
Start: 04/19/23 End: 11/28/25 Due: 11/28/26

A Study to to Assess the Effect of Dapagliflozin When Administered Once a Day Versus Twice a Day on Blood Glucose

Phase: N/A Priority: Normal
NCT ID: NCT01072578 Org: User:
Start: 02/28/10 End: 04/30/10 Due: 04/30/11

Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00711074 Org: User:
Start: 06/30/08 End: 07/31/08 Due: 07/31/09

Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00837629 Org: User:
Start: 02/28/07 End: 09/30/07 Due: 09/30/08

AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in Pediatrics

Phase: N/A Priority: Normal
NCT ID: NCT05281601 Org: User:
Start: 03/21/22 End: 04/16/24 Due: 04/16/25